Theranos Investor Conference Presentation Deck

Multi-miniLab Precision Study Design 3 devices 5 days 5 tests miniLab 1 Repeatability (within-run/day) one day-one device baseline variance of assay system miniLab 2 Within-laboratory (within-miniLab) intermediate precision, includes day-to-day variability CLSI EP05-A3 This technology has not been cleared or approved by the FDA and is not for sale in the United States. miniLab 3 Reproducibility encompasses imprecision across multiple devices or sites theranos 24

View entire presentation